Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
Malaria Journal
|
September 30, 2015
The challenges of introducing routine G6PD testing into radical cure: a workshop report
Benedikt Ley, Nick Luter, Fe Esperanza Espino, et al.
Malaria Journal
|
December 1, 2022
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
Ashenafi Assefa, Hussein Mohammed, Anjoli Anand, et al.
The Lancet. Infectious Diseases
|
February 10, 2018
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial
Alassane Dicko, Michelle E Roh, Halimatou Diawara, et al.
Malaria Journal
|
April 11, 2023
Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
Ashenaf Assefa, Hussein Mohammed, Anjoli Anand, et al.
BMJ Global Health
|
January 29, 2025
An observational study evaluating the epidemiological and entomological impacts of piperonyl butoxide insecticide-treated nets (ITNs) compared to a combination of indoor residual spraying (IRS) plus standard pyrethroid-only ITNs in Amhara Region, Ethiopia, 2019-2023
Kelly M Davis, Amha Worku, Meshesha Balkew, et al.
The Lancet. Microbe
|
June 8, 2026
Efficacy of chloroquine plus low-dose primaquine and pyronaridine-artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial
Migbaru Keffale Bezabih, Solomon Sisay, Sinknesh Wolde Behaksera, et al.
Emerging Infectious Diseases
|
November 21, 2017
Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa Network
Eric S Halsey, Meera Venkatesan, Mateusz M Plucinski, et al.
Malaria Journal
|
November 6, 2013
G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests
Gonzalo J Domingo, Ari Winasti Satyagraha, Anup Anvikar, et al.
The Lancet. Infectious Diseases
|
January 12, 2025
Effect of mass drug administration on malaria incidence in southeast Senegal during 2020-22: a two-arm, open-label, cluster-randomised controlled trial
El-Hadji Konko Ciré Ba, Michelle E Roh, Abdoulaye Diallo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 29, 2024
Mass drug administration to reduce malaria incidence in a low-to-moderate endemic setting: short-term impact results from a cluster randomised controlled trial in Senegal
El-Hadji Ba Konko Ciré, Michelle E Roh, Abdoulaye Diallo, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
Malaria Journal
|
September 30, 2015
The challenges of introducing routine G6PD testing into radical cure: a workshop report
Benedikt Ley, Nick Luter, Fe Esperanza Espino, et al.
Malaria Journal
|
December 1, 2022
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
Ashenafi Assefa, Hussein Mohammed, Anjoli Anand, et al.
The Lancet. Infectious Diseases
|
February 10, 2018
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial
Alassane Dicko, Michelle E Roh, Halimatou Diawara, et al.
Malaria Journal
|
April 11, 2023
Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
Ashenaf Assefa, Hussein Mohammed, Anjoli Anand, et al.
BMJ Global Health
|
January 29, 2025
An observational study evaluating the epidemiological and entomological impacts of piperonyl butoxide insecticide-treated nets (ITNs) compared to a combination of indoor residual spraying (IRS) plus standard pyrethroid-only ITNs in Amhara Region, Ethiopia, 2019-2023
Kelly M Davis, Amha Worku, Meshesha Balkew, et al.
The Lancet. Microbe
|
June 8, 2026
Efficacy of chloroquine plus low-dose primaquine and pyronaridine-artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial
Migbaru Keffale Bezabih, Solomon Sisay, Sinknesh Wolde Behaksera, et al.
Emerging Infectious Diseases
|
November 21, 2017
Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa Network
Eric S Halsey, Meera Venkatesan, Mateusz M Plucinski, et al.
Malaria Journal
|
November 6, 2013
G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests
Gonzalo J Domingo, Ari Winasti Satyagraha, Anup Anvikar, et al.
The Lancet. Infectious Diseases
|
January 12, 2025
Effect of mass drug administration on malaria incidence in southeast Senegal during 2020-22: a two-arm, open-label, cluster-randomised controlled trial
El-Hadji Konko Ciré Ba, Michelle E Roh, Abdoulaye Diallo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 29, 2024
Mass drug administration to reduce malaria incidence in a low-to-moderate endemic setting: short-term impact results from a cluster randomised controlled trial in Senegal
El-Hadji Ba Konko Ciré, Michelle E Roh, Abdoulaye Diallo, et al.
Page
of 9